Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab

Thyroid eye disease (TED) causes orbital soft-tissue expansion. Recent studies have suggested that brow and temple changes may also occur. Teprotumumab, a monoclonal antibody to the insulin-like growth factor 1 receptor reduces soft-tissue swelling in TED. In this study, we quantified the changes to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ugradar, Shoaib, Braun, Jenna, Wang, Yao, Zimmerman, Erin, Douglas, Raymond S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Craniofacial/Pediatric
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443810/
https://www.ncbi.nlm.nih.gov/pubmed/34549003
http://dx.doi.org/10.1097/GOX.0000000000003809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443810/
https://www.ncbi.nlm.nih.gov/pubmed/34549003
http://dx.doi.org/10.1097/GOX.0000000000003809

Ejemplares similares